|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leslie A and Steele RJ: Management of
colorectal cancer. Postgrad Med J. 78:473–478. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Renkonen-Sinisalo L, Aarnio M, Mecklin JP
and Järvinen HJ: Surveillance improves survival of colorectal
cancer in patients with hereditary nonpolyposis colorectal cancer.
Cancer Detect Prev. 24:137–142. 2000.PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen W, Zheng R, Zeng H, Zhang S and He J:
Annual report on status of cancer in China, 2011. Chin J Cancer
Res. 27:2–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Derry MM, Raina K, Agarwal C and Agarwal
R: Identifying molecular targets of lifestyle modifications in
colon cancer prevention. Front Oncol. 3:1192013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sakai E, Fukuyo M, Ohata K, Matsusaka K,
Doi N, Mano Y, Takane K, Abe H, Yagi K, Matsuhashi N, et al:
Genetic and epigenetic aberrations occurring in colorectal tumors
associated with serrated pathway. Int J Cancer. 138:1634–1644.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mlcochova J, Faltejskova P, Nemecek R,
Svoboda M and Slaby O: MicroRNAs targeting EGFR signalling pathway
in colorectal cancer. J Cancer Res Clin Oncol. 139:1615–1624. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takahashi T, Shigematsu H, Shivapurkar N,
Reddy J, Zheng Y, Feng Z, Suzuk M, Nomura M, Augustus M, Yin J, et
al: Aberrant promoter methylation of multiple genes during
multistep pathogenesis of colorectal cancers. Int J Cancer.
118:924–931. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schirripa M and Lenz HJ: Biomarker in
Colorectal Cancer. Cancer J. 22:156–164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bustin SA and Dorudi S: Gene expression
profiling for molecular staging and prognosis prediction in
colorectal cancer. Expert Rev Mol Diagn. 4:599–607. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kulasingam V and Diamandis EP: Strategies
for discovering novel cancer biomarkers through utilization of
emerging technologies. Nat Clin Pract Oncol. 5:588–599. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nannini M, Pantaleo MA, Maleddu A, Astolfi
A, Formica S and Biasco G: Gene expression profiling in colorectal
cancer using microarray technologies: Results and perspectives.
Cancer Treat Rev. 35:201–209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang B, Li C and Zhao J: Identification
of key pathways and genes in colorectal cancer using bioinformatics
analysis. Med Oncol. 33:1112016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Skrzypczak M, Goryca K, Rubel T, Paziewska
A, Mikula M, Jarosz D, Pachlewski J, Oledzki J and Ostrowski J:
Modeling oncogenic signaling in colon tumors by multidirectional
analyses of microarray data directed for maximization of analytical
reliability. PLoS One. 5:e130912010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Condorelli DF, Spampinato G, Valenti G,
Musso N, Castorina S and Barresi V: Positive caricature
transcriptomic effects associated with broad genomic aberrations in
colorectal cancer. Sci Rep. 8:148262018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ryan BM, Zanetti KA, Robles AI, Schetter
AJ, Goodman J, Hayes RB, Huang WY, Gunter MJ, Yeager M, Burdette L,
et al: Germline variation in NCF4, an innate immunity gene, is
associated with an increased risk of colorectal cancer. Int J
Cancer. 134:1399–1407. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rich JN, Hans C, Jones B, Iversen ES,
McLendon RE, Rasheed BK, Dobra A, Dressman HK, Bigner DD, Nevins JR
and West M: Gene expression profiling and genetic markers in
glioblastoma survival. Cancer Res. 65:4051–4058. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Simon R, Lam A, Li MC, Ngan M, Menenzes S
and Zhao Y: Analysis of gene expression data using BRB-array tools.
Cancer Inform. 3:11–17. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
von Mering C, Huynen M, Jaeggi D, Schmidt
S, Bork P and Snel B: STRING: A database of predicted functional
associations between proteins. Nucleic Acids Res. 31:258–261. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Otte E and Rousseau R: Social network
analysis: A powerful strategy, also for the information sciences. J
Inform Sci. 28:441–453. 2002. View Article : Google Scholar
|
|
24
|
Rhrissorrakrai K and Gunsalus KC: MINE:
Module identification in networks. BMC Bioinformatics. 12:1922011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto Encyclopedia of Genes and Genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Merico D, Isserlin R, Stueker O, Emili A
and Bader GD: Enrichment map: A network-based method for gene-set
enrichment visualization and interpretation. PLoS One.
5:e139842010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang SH, Xu W, Waldron J, Siu L, Shen X,
Tong L, Ringash J, Bayley A, Kim J, Hope A, et al: Refining
American Joint Committee on Cancer/Union for International Cancer
Control TNM stage and prognostic groups for human
papillomavirus-related oropharyngeal carcinomas. J Clin Oncol.
33:836–845. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ramaswamyreddy SH and Smitha T:
Microarray-based gene expression profiling for early detection of
oral squamous cell carcinoma. J Oral Maxillofac Pathol. 22:293–295.
2018.PubMed/NCBI
|
|
31
|
Salem H, Attiya G and El-Fishawy N:
Classification of human cancer diseases by gene expression
profiles. Appl Soft Comput. 50:124–134. 2017. View Article : Google Scholar
|
|
32
|
Li G, Li X, Yang M, Xu L, Deng S and Ran
L: Prediction of biomarkers of oral squamous cell carcinoma using
microarray technology. Sci Rep. 7:421052017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Romero MF, Hediger MA, Boulpaep EL and
Boron WF: Expression cloning and characterization of a renal
electrogenic Na+/HCO3-cotransporter. Nature. 387:409–413. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Romero MF, Fulton CM and Boron WF: The
SLC4 family of HCO 3-transporters. Pflugers Arch. 447:495–509.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gomez-Rueda H, Palacios-Corona R,
Gutiérrez-Hermosillo H and Trevino V: A robust biomarker of
differential correlations improves the diagnosis of cytologically
indeterminate thyroid cancers. Int J Mol Med. 37:1355–1362. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen S, Zhang L, Su Y and Zhang X:
Screening potential biomarkers for colorectal cancer based on
circular RNA chips. Oncol Rep. 39:2499–2512. 2018.PubMed/NCBI
|
|
37
|
Zhao ZW, Fan XX, Yang LL, Song JJ, Fang
SJ, Tu JF, Chen MJ, Zheng LY, Wu FZ, Zhang DK, et al: The
identification of a common different gene expression signature in
patients with colorectal cancer. Math Biosci Eng. 16:2942–2958.
2019.PubMed/NCBI
|
|
38
|
Bisbal C, Martinand C, Silhol M, Lebleu B
and Salehzada T: Cloning and Characterization of a RNase L
Inhibitor A new component of the interferon-regulated 2-5A pathway.
J Biol Chem. 270:13308–13317. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pestka S, Langer JA, Zoon KC and Samuel
CE: Interferons and their actions. Annu Rev Biochem. 56:727–777.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zheng D, Dai Y, Wang S and Xing X:
MicroRNA-299-3p promotes the sensibility of lung cancer to
doxorubicin through directly targeting ABCE1. Int J Clin Exp
Pathol. 8:10072–10081. 2015.PubMed/NCBI
|
|
41
|
Hlavata I, Mohelnikova-Duchonova B,
Vaclavikova R, Liska V, Pitule P, Novak P, Bruha J, Vycital O,
Holubec L, Treska V, et al: The role of ABC transporters in
progression and clinical outcome of colorectal cancer. Mutagenesis.
27:187–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang B, Zhou H, Lang X and Liu Z:
siRNA-induced ABCE1 silencing inhibits proliferation and invasion
of breast cancer cells. Mol Med Rep. 10:1685–1690. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang B, Gao Y, Tian D and Zheng M: A
small interfering ABCE1-targeting RNA inhibits the proliferation
and invasiveness of small cell lung cancer. Int J Mol Med.
25:687–693. 2010.PubMed/NCBI
|
|
44
|
Shichijo S, Ishihara Y, Azuma K, Komatsu
N, Higashimoto N, Ito M, Nakamura T, Ueno T, Harada M and Itoh K:
ABCE1, a member of ATP-binding cassette transporter gene, encodes
peptides capable of inducing HLA-A2-restricted and tumor-reactive
cytotoxic T lymphocytes in colon cancer patients. Oncol Rep.
13:907–913. 2005.PubMed/NCBI
|
|
45
|
Wang YY, Li L, Zhao ZS and Wang HJ:
Clinical utility of measuring expression levels of KAP1, TIMP1 and
STC2 in peripheral blood of patients with gastric cancer. World J
Surg Oncol. 11:812013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bjerre C, Vinther L, Belling KC, Würtz SØ,
Yadav R, Lademann U, Rigina O, Do KN, Ditzel HJ, Lykkesfeldt AE, et
al: TIMP1 overexpression mediates resistance of MCF-7 human breast
cancer cells to fulvestrant and down-regulates progesterone
receptor expression. Tumour Biol. 34:3839–3851. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Peng L, Yanjiao M, Ai-Guo W, Pengtao G,
Jianhua L, Ju Y, Hongsheng O and Xichen Z: A fine balance between
CCNL1 and TIMP1 contributes to the development of breast cancer
cells. Biochem Biophys Res Commun. 409:344–349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xiong Y, You W, Wang R, Peng L and Fu Z:
Prediction and validation of Hub Genes associated with colorectal
cancer by integrating PPI network and gene expression data. Biomed
Res Int. 2017:24214592017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Song G, Xu S, Zhang H, Wang Y, Xiao C,
Jiang T, Wu L, Zhang T, Sun X, Zhong L, et al: TIMP1 is a
prognostic marker for the progression and metastasis of colon
cancer through FAK-PI3K/AKT and MAPK pathway. J Exp Clin Cancer
Res. 35:1482016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kostourou V, Lechertier T, Reynolds LE,
Lees DM, Baker M, Jones DT, Tavora B, Ramjaun AR, Birdsey GM,
Robinson SD, et al: FAK-heterozygous mice display enhanced tumour
angiogenesis. Nat Commun. 4:20202013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Oudart JB, Doué M, Vautrin A, Brassart B,
Sellier C, Dupont-Deshorgue A, Monboisse JC, Maquart FX,
Brassart-Pasco S and Ramont L: The anti-tumor NC1 domain of
collagen XIX inhibits the FAK/PI3K/Akt/mTOR signaling pathway
through αvβ3 integrin interaction. Oncotarget. 7:1516–1528. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kapur R, Cooper R, Zhang L and Williams
DA: Cross-talk between alpha(4)beta(1)/alpha(5)beta(1) and c-Kit
results in opposing effect on growth and survival of hematopoietic
cells via the activation of focal adhesion kinase,
mitogen-activated protein kinase, and Akt signaling pathways.
Blood. 97:1975–1981. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ko HH, Cheng SL, Lee JJ, Chen HM, Kuo MY
and Cheng SJ: Expression of AKR1B10 as an independent marker for
poor prognosis in human oral squamous cell carcinoma. Head Neck.
39:1327–1332. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sinreih M, Štupar S, Čemažar L, Verdenik
I, Frković Grazio S, Smrkolj Š and Rižner TL: STAR and AKR1B10 are
down-regulated in high-grade endometrial cancer. J Steroid Biochem
Mol Bio. 171:43–53. 2017. View Article : Google Scholar
|
|
55
|
Huang B, Gong X, Zhou H, Xiong F and Wang
S: Depleting ABCE1 expression induces apoptosis and inhibits the
ability of proliferation and migration of human esophageal
carcinoma cells. Int J Clin Exp Pathol. 7:584–592. 2014.PubMed/NCBI
|
|
56
|
Li Q, Shen F and Wang C: TUC338 promotes
cell migration and invasion by targeting TIMP1 in cervical cancer.
Oncol Lett. 13:4526–4532. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Petitjean A, Mathe E, Kato S, Ishioka C,
Tavtigian SV, Hainaut P and Olivier M: Impact of mutant p53
functional properties on TP53 mutation patterns and tumor
phenotype: Lessons from recent developments in the IARC TP53
database. Hum Mutat. 28:622–629. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Taskoparan B, Seza EG, Demirkol S, Tuncer
S, Stefek M, Gure AO and Banerjee S: Opposing roles of the
aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer. Cell
Oncol (Dordr). 40:563–578. 2017. View Article : Google Scholar : PubMed/NCBI
|
